Economic Evaluation of Everolimus as Second-Line Treatment of Metastatic Renal Cell Carcinoma in Greece
Abstract
Authors
A Solakidi G Kourlaba L Kontovinis K Koutsoukos E Bournakis A Boutis J Syrios A Tzovaras C Michailidi M Kalogeropoulou N Maniadakis